medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2009, Number 1

<< Back Next >>

An Med Asoc Med Hosp ABC 2009; 54 (1)

Implications and challenges to achieve therapeutic goals in hypertensive patients with metabolic syndrome

Rosales CM, Lerman GI, Ramos GMA, Espinosa AL, Magaña CF

Language: Spanish
References: 17
Page: 10-15
PDF size: 81.08 Kb.


ABSTRACT

Hypertension is one of the major cardiovascular risk factors importantly affected by the coexistence with metabolic syndrome. Hypertensive patients with metabolic syndrome usually need significant changes in their life style and may have more difficulty in achieving therapeutic goals. The objective of the present study was to evaluate the treatment and achievement of therapeutic goals in hypertensive patients with and without metabolic syndrome. Methods: Cross sectional study, 200 consecutive hypertensive patients who attended a Preventive Medical Service were included. Complete medical history, anthropometrical measurements and laboratory studies were obtained. Results: The prevalence of the metabolic syndrome within the hypertensive population was 41.5%. When comparing previously known hypertensive patients with and without the metabolic syndrome, those with the metabolic syndrome had as expected, more comorbidities. However, there was a reduced number of patients treated with lipid lowering agents (20%) or aspirin (2%) and fewer patients with metabolic syndrome achieved the goals for blood pressure control (37.5 vs 60%, p ‹ 0.001). Conclusions: Metabolic syndrome is a common problem in the hypertensive population; patients are usually not screened or treated aggressively for the different components of the syndrome. Integral management of the hypertensive patient is urgently needed.


REFERENCES

  1. Velázquez-Monroy O, Rosas PM, Lara EA, Pastelín-Hernández G, Grupo ENSA 2000, Castillo C et al. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México. Arch Cardiol Mex 2003; 73: 62-77.

  2. National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. US Department of Health and Human Services. National Institutes of Health. National Cholesterol Education Program. Hypertension 2003; 42 (6): 1206-1252.

  3. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.

  4. Phillippa J, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: Definition, pathophysiology, and mechanisms. Am Heart J 2005; 149: 33-45.

  5. Haffner SM. Risk constellations in patients with the metabolic syndrome. Epidemiology, diagnosis, and treatment patterns. Am J Med 2006; 119 (5) suppl 1: S3-S9.

  6. Aguilar-Salinas CA, Rojas R, Gomez PFJ, Valles V, Rios TJM, Franco A, Olaiz G, Rull JA, Sepulveda J. High prevalence of metabolic syndrome in Mexico. Arch Med Research 2004; 35: 76-81.

  7. Gómez PFJ, Torres JM, Aguilar SCA, Lerman GI, Rull JA. Posición de la SMNE sobre el manejo del síndrome metabólico (2a parte). Rev Endocrinol Nutr 2005; 13 (1): 1116-1130.

  8. Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts, and different goals. Endocrinol Metabol Clin N Am 2004; 33: 283-303.

  9. Natali A, Ferrannini E. Hypertension insulin resistance, and the metabolic syndrome. Endocrinol Metab Clin N Am 2004; 33: 417-429.

  10. Velázquez MO, Rosas PM, Lara EA, Pastelín HG. Hipertensión arterial en México: Resultados de la Encuesta Nacional de Salud (ENSA) 2000. Arch Cardiol Mex 2000; 71 (1): 71-84.

  11. Branch WT. The ethics of caring and medical education. Acad Med 2000; 75: 127.

  12. McDonald HP. Interventions to enhance patient adherence to medication prescriptions: Scientific review. JAMA 2002; 288: 2868-2875.

  13. Hynes RB. Helping patients follow prescribed treatment: Clinical implications. JAMA 2002; 288: 2880-2887.

  14. Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433-438.

  15. Larrad MT, Sanchez JG, Gonzalez GR, Rios MS. Arterial hypertension and metabolic syndrome in based study in Spain. Diabetes 2002; 51 (2): A585-A586.

  16. Reaven GM. Insulin resistance/compensatory hyperinsulinemia, essential hypertension, and cardiovascular disease. J Clin Endoc Metab 2003; 88 (6): 2399-2403.

  17. Legato MJ, Gelzer A, Goland R, Ebner SA, Rajan S, Villagra V, Kosowski M. Gender-specific care of patient with diabetes: Review and recommendations. Gend Med 2006; 3 (2): 131-158.




2020     |     www.medigraphic.com